| Key Financial Ratios of Jubilant Pharmova (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
1.21 |
1.99 |
3.13 |
4.93 |
13.47 |
|
| Diluted EPS (Rs.) |
1.21 |
1.99 |
3.13 |
4.93 |
13.47 |
|
| Cash EPS (Rs.) |
4.55 |
5.03 |
5.85 |
5.32 |
19.74 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
145.79 |
149.34 |
151.57 |
80.47 |
80.51 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
145.79 |
149.34 |
151.57 |
80.47 |
80.51 |
|
| Dividend / Share(Rs.) |
5.00 |
5.00 |
5.00 |
5.00 |
5.00 |
|
| Revenue from Operations/Share (Rs.) |
46.90 |
49.35 |
50.85 |
5.51 |
170.09 |
|
| PBDIT/Share (Rs.) |
8.28 |
7.54 |
8.86 |
7.48 |
29.81 |
|
| PBIT/Share (Rs.) |
4.94 |
4.50 |
6.14 |
7.08 |
23.54 |
|
| PBT/Share (Rs.) |
2.36 |
2.62 |
4.98 |
5.16 |
17.15 |
|
| Net Profit/Share (Rs.) |
1.21 |
1.99 |
3.13 |
4.93 |
13.46 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
17.66 |
15.27 |
17.41 |
135.70 |
17.52 |
|
| PBIT Margin (%) |
10.54 |
9.12 |
12.08 |
128.58 |
13.83 |
|
| PBT Margin (%) |
5.04 |
5.31 |
9.79 |
93.73 |
10.08 |
|
| Net Profit Margin (%) |
2.57 |
4.02 |
6.15 |
89.46 |
7.91 |
|
| Return on Networth / Equity (%) |
0.82 |
1.33 |
2.06 |
6.12 |
16.72 |
|
| Return on Capital Employed (%) |
3.02 |
2.67 |
3.69 |
6.29 |
21.74 |
|
| Return on Assets (%) |
0.65 |
1.05 |
1.65 |
4.29 |
11.62 |
|
| Total Debt/Equity (X) |
0.13 |
0.14 |
0.12 |
0.39 |
0.38 |
|
| Asset Turnover Ratio (%) |
0.25 |
0.26 |
0.33 |
0.05 |
146.88 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.56 |
1.71 |
1.60 |
1.27 |
0.55 |
|
| Quick Ratio (X) |
0.81 |
0.92 |
0.73 |
1.27 |
0.55 |
|
| Inventory Turnover Ratio (X) |
3.09 |
1.10 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (NP) (%) |
414.58 |
251.89 |
159.65 |
101.44 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
110.09 |
99.62 |
85.51 |
93.96 |
0.00 |
|
| Earnings Retention Ratio (%) |
-314.58 |
-151.89 |
-59.65 |
-1.44 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
-10.09 |
0.38 |
14.49 |
6.04 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
14,487.43 |
9,345.95 |
4,735.77 |
6,654.15 |
11,291.45 |
|
| EV/Net Operating Revenue (X) |
19.43 |
11.91 |
5.85 |
75.83 |
4.17 |
|
| EV/EBITDA (X) |
110.00 |
77.95 |
33.56 |
55.88 |
23.77 |
|
| MarketCap/Net Operating Revenue (X) |
19.03 |
11.52 |
5.49 |
70.40 |
4.00 |
|
| Retention Ratios (%) |
-314.58 |
-151.89 |
-59.65 |
-1.44 |
0.00 |
|
| Price/BV (X) |
6.12 |
3.81 |
1.84 |
4.82 |
8.45 |
|
| Price/Net Operating Revenue |
19.03 |
11.52 |
5.49 |
70.40 |
4.00 |
|
| Earnings Yield |
0.00 |
0.00 |
0.01 |
0.01 |
0.02 |
|
Source : Dion Global Solutions Limited
